Roche Holding Ltd ADR (RHHBY OTCQX) stock market data APIs
$45.5829
-0.54(-1.2%)
as of November 12, 2025
Try our APIs with
free plan!
Roche Holding Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
45.5829
Open
45.0439
High
45.367
Low
45.286
52 wk Range
33.0054-45.94
Market Cap
290 397 M
P/E Ratio
24.6902
Shares Outstanding
5 517 M
Revenue
63 488 M
EPS
0
Dividends (Yield)
0.0306
Beta
0.169
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roche Holding Ltd ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding Ltd ADR data using free add-ons & libraries
Get Roche Holding Ltd ADR Fundamental Data
Roche Holding Ltd ADR Fundamental data includes:
- Net Revenue: 63 488 M
- EBITDA: 23 429 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-23
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding Ltd ADR News
New
RHHBY Reaches Analyst Target Price
In recent trading, shares of RHHBY (Symbol: RHHBY) have crossed above the average analyst 12-month target price of $44.88, changing hands for $45.43/share. When a stock reaches the target an analyst ...
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
New research shows that people aged 29-42 are more likely to miss cervical screenings than any other age group.1 Almost one third of surveyed European millennials eligible for routine cervical screen...
Roche posts late-stage trial wins for new multiple sclerosis therapy
[Roche Diagnostics campus facade in Silicon Valley] Michael Vi/iStock Editorial via Getty Images Roche (OTCQX:RHHBY [https://seekingalpha.com/symbol/RHHBY]) shares closed ~4% higher in Europe on Mond...
Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
- The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses compared to teriflunomide - - In a pivotal PPMS study...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
